Research & Scholarship

Please see some of the Division’s research projects at:
https://med.uth.edu/internalmedicine/oncology/research/


Abstracts & Presentations


2025 San Antonio Breast Cancer Symposium
Giza D, Gonzalez A, Doostan I, Basbayraktar B, Mera A, Yalavarty G, Barrera J, Karuturi M, Ghosh S. Holmes, H., and Naik, A.: Patient priorities for breast cancer survivorship: a preliminary descriptive analysis of the health outcome goals that matter most to older adults breast cancer survivors. Abstract PS5-04-23.

2025 ASCO Annual Meeting
Ningjing Li, Christiaan Van Der Weiden, Bernadette Tumaliuan, Sofia Colon, Varaha Tammisetti, Putao Cen, Curtis Jackson Wray, Jennifer M. Bailey-Lundberg, Nirav Thosani, and Julie Haewon Rowe. A single-center experience of chemotherapy combined with radiofrequency ablation and immunotherapy in patients with locally advanced/metastatic pancreatic ductal adenocarcinoma

2024 SOHO Meeting
Sara Soliman, Ningjing Li, Sara Taveras Alam, Rachel Newman, Sean Blackwell, Sibai Baha, Adan Rios. Hematological malignancies and pregnancy: a single-institution experience

Cristina Olivo-Freites, Wesley Hill, Romil Patel, Asad Haider, Ledian Memushaj, Jodi Schnuriger, Sara Taveras, Adan Rios. Primary mediastinal B-cell lymphoma: experience at a general hospital in Houston, Texas

Cristina Olivo-Freites, Asad Haider, Sara Taveras, Adan Rios. Treatment of acute promyelocytic leukemia in patients with renal failure on hemodialysis

Adan Rios, Kok Hoe Chan, Binoy Yohannan, Asad Haider, Brian Dinh, Pushan P. Jani, Jacob A. Armstrong, Sara Taveras. Burkitt’s lymphoma (BL) responding to rituximab-cyclophosphamide-vincristine-dexamethasone-lenalidomide: Time for a paradigm shift?

Asad Haider, Sara Taveras, Ledian Memushaj, Joshua Esquenazi, P. Roc Chen, Adan Rios. Myeloid sarcoma of the brain: a case series

2023 San Antonio Breast Cancer Symposium
Rabab Jafry, Hina Khan, Jessica Jones.A case of multifocal ductal breast carcinoma with extension into lobules and concurrent primary colon adenocarcinoma. Abstract: PO5-20-08

2023 ASCO GU Meeting
Sridhar A, Yohannan B, Kaur H, Maithel N. De novo prostate cancer in renal transplant recipients: A single-center study. Abstract 326 (390126). Presented at ASCO GU Symposium, February 2023, San Francisco, CA

Sridhar A, Yohannan B, Kaur H, Maithel N. Clinical outcomes of renal transplant recipients with prostate cancer: A single center retrospective study. Presented at ASCO GU meeting, February 2023, San Francisco, CA

2023 ASH Annual Meeting
Oren Pasvolsky, Sarah Pasyar, Roland L. Bassett, Hina N. Khan, Mark R. Tanner, Qaiser Bashir, Samer A. Srour, Neeraj Y. Saini, Paul Lin, Jeremy Ramdial, Yago Nieto, Hans C. Lee, Krina K. Patel, Partow Kebriaei, Sheeba K. Thomas, Donna M. Weber, Robert Z. Orlowski, Elizabeth J. Shpall, Richard E. Champlin, Muzaffar H. Qazilbash. Impact of pre-transplant minimal residual disease in patients with multiple myeloma with ≥ very good partial response receiving autologous hematopoietic stem cell transplantation. doi: https://doi.org/10.1182/blood-2023-173040

Muzaffar H. Qazilbash, Hina N. Khan, Denái R. Milton, Oren Pasvolsky, Mark R. Tanner, Uday R. Popat, Partow Kebriaei, Chitra Hosing, Issa F. Khouri, Katayoun Rezvani, Yago Nieto, Betul Oran, Samer A. Srour, Neeraj Y. Saini, Amanda L. Olson, Sairah Ahmed, Gheath Alatrash, Gabriela Rondon, Marina Y. Konopleva, Richard E. Champlin, Elizabeth J. Shpall, Qaiser Bashir, Naveen Pemmaraju. Patient characteristics and outcomes of allogeneic hematopoietic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm (BPDCN). doi: https://doi.org/10.1182/blood-2023-181031

Oren Pasvolsky, Sassine Ghanem, Denái R. Milton, Mikael Rauf, Mark R. Tanner, Qaiser Bashir, Samer A. Srour, Neeraj Y. Saini, Paul Lin, Jeremy Ramdial, Yago Nieto, Hina N. Khan, Partow Kebriaei, Hans C. Lee, Krina K. Patel, Sheeba K. Thomas, Donna M. Weber, Robert Z. Orlowski, Elizabeth J. Shpall, Richard E. Champlin, Muzaffar H. Qazilbash. Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson Cancer Center Experience. doi: https://doi.org/10.1182/blood-2023-173697

Jia Yi Tan, Yong Hao Yeo, Kok Hoe Chan, Hamid Shaaban, Gunwant Guron. Mortality trends and causes of death in individuals with thalassemia: a population-based retrospective study in the United States from 1999 to 2020. doi:https://ashpublications.org/blood/article/142/Supplement1/3740/506266/

Zean Liao, Kok Hoe Chan, Modupe Idowu. The renal protective effect of sickle cell disease–modifying drugs. doi: https://ashpublications.org/blood/article/142/Supplement1/1147/505800/

Kok Hoe Chan, Zean Liao, Modupe Idowu. A comprehensive echocardiographic portrait of adult sickle cell disease patients in the modern era. doi: https://ashpublications.org/blood/article/142/Supplement1/5318/503136

Hina N. Khan, Anjali Lankford, Ugochi Ebinama, Akshar Dash, Athira Jayan, Modupe Idowu. Improving interprofessional communication in the outpatient hematology clinic at a metropolitan cancer center. doi: https://ashpublications.org/blood/article/142/Supplement1/7222/504467

Luan Hai Phan, Nehaa Dambala, Sama Ilyas, Kok Hoe Chan, Modupe Idowu. Sickle cell disease and comorbid psychiatric conditions: a single-center retrospective study. https://ashpublications.org/blood/article/142/Supplement1/5342/504251/

2023 AACR Annual Meeting
Chan KH, Lin J, Sridhar A, Jafri SH. Genomic profiling and sites of metastasis in non-small cell lung cancer (NSCLC).

Leukemia, Lymphoma, & Myeloma Conference, October 18-22, 2022
Chan KH, Yohannan B, Lin JZ, Rios A. Myeloid sarcoma: A retrospective analysis in a general community hospital. Abstract 1328105

Yohannan B, Rios A. Clinical outcomes of acute myeloid leukemia patients with central nervous system disease: A single center retrospective study

European Hematology Association Congress 2022
Binoy Yohannan, Frances-Cervoni Curet, Adan Rios. Early deaths in patients with newly diagnosed acute promyelocytic leukemia: A single-center retrospective study from a general hospital (abstract PB1851)

SOHO Annual Meeting 2022
Adan Rios, Binoy Yohannan, Frances Cervoni-Curet. Induction mortality (IM) of acute myeloid leukemia (AML) patients treated with purine analogues-cytarabine-anthracycline at a general hospital (abstract soho2022.03a0037)

Binoy Yohannan, Frances Cervoni-Curet, Arthi Sridhar, Wei Yang, Adan Rios. Clinical outcomes of patients with FLT3-mutated acute myeloid leukemia (AML): A single-center retrospective review (abstract soho2022.03e0038)

Adan Rios, Binoy Yohannan, Frances Cervoni-Curet, Angel I. Blanco. Unique pattern of intracranial relapse of multiple myeloma (MM) after autologous stem cell transplantation (ASCT) (abstract soho2022.1580037)

Nithin Thomas, Binoy Yohannan, Arthi Sridhar, Adan Rios. Myeloproliferative neoplasm (MPN) post-renal transplant (RT)—A single-center review (abstract soho2022.MPN.166)

 Binoy Yohannan, Frances Cervoni-Curet, Adan Rios. Pseudotumor cerebri (PTC) in patients with Acute Leukemia (AL) (abstract soho2022.03f0038)

Binoy Yohannan, Frances Cervoni-Curet, Adan Rios. Early deaths in patients with newly diagnosed acute promyelocytic leukemia: A single-center retrospective study from a general hospital (abstract soho2022.03b0038)

Adan Rios, Binoy Yohannan, Angel I. Blanco, Frances Cervoni-Curet. Primary cranial vault lymphoma: Review of cases diagnosed at a general hospital (abstract soho2022.09f0037)

Binoy Yohannan, Frances Cervoni-Curet, Adan Rios. A single institution experience on clinical outcomes of TP-53 mutant acute myeloid leukemia (AML) (abstract soho2022.0410038)

2022 Internal Medicine Quality Fair, September 2022
Simbiat Olayiwola, Saumil Datar, Zoe Alaniz, Andrew Zarker, Jeffrey Chen, Arthi Sridhar, Hina Khan, Modupe Idowu, John Hancock. Improving physician confidence in the diagnosis and treatment of TTP/HUS (TMA) with an order set – Modified version of the TTP/HUS order set (won 3rd place)

Shane Wing, Binoy Yohannan, Adan Rios. A risk adapted strategy for prevention of tumor lysis syndrome (TLS): A quality improvement (QI) project

Athira Jayan, Akshar Dash, Yusuf Chang, Wei Yang, Arthi Sridhar, Hina Khan, Angela Sheng, Jaanki Khandelwal. Improving new cancer diagnosis education in the Memorial Herman Cancer Center

Ijele Adimora, Ugochi Ebinama, Alexandria Koney, Naveen Subramanian, Reid Davison, Ji Lin, Evan Abdullah, Jordan Thomas, Shelby Irwin, Arthi Sridhar, Modupe Idowu. Implementing a standardized electronic medical record order set to reduce emergency department wait times for sickle cell patients in acute vaso-occlusive crisis

ASCO Quality Conference, September 30, 2022
Arthi Sridhar, Wei Yang, Hina Khan, Neha Maithel, Kok Hoe Chan, Athira Jayan, Akshar Dash, Chang Yusuf. Improving new cancer diagnosis education in a metropolitan cancer center

ASCO Annual Meeting, Chicago, IL, June 3-7, 2022
Binoy Yohannan, Arthi Sridhar, Harmanpreet Kaur, Aleksandra De Golovine, Neha Maithel. Renal cell carcinoma in renal transplant recipients: is there a role for screening? [abstract 10528]

Adan Rios, Binoy Yohannan, Frances Cervoni-Curet. Induction mortality (IM) of acute myeloid leukemia (AML) patients treated with purine analogues-cytarabine-anthracycline at a general hospital. J Clin Oncol 2022;40(suppl 16; abstr e19019)

Frances Cervoni-Curet, Adan Rios, Binoy Yohannan. Treatment of patients with hematologic malignancies and left ventricular assisted device (LVAD) managed cardiomyopathy J Clin Oncol 2022;40(suppl 16; abstr e19581)

Arthi Sridhar, Chandler H. Nguyen, Kamelah Abushalha, Iqra Saghir, Amirali Tahanan, Mohammad Hossein Rahbar, Syed Hasan Raza Jafri. Major stressful events and risk of developing head/neck and pancreatic cancer

Cervoni-Curet F, Rios A, Yohannan B. Treatment of patients with hematologic malignancies and left ventricular assisted device (LVAD) managed cardiomyopathy. J Clin Oncol 2022;40(16 suppl), e19581-e19581. doi: 10.1200/JCO.2022.40.16_suppl.e19581

Yohannan B, Cervoni-Curet F, Rios A. AML-156 early deaths in patients with newly diagnosed acute promyelocytic leukemia: a single-center retrospective study from a general hospital. Clin Lymphoma Myeloma Leuk. 2022 Oct;22 Suppl 2:S219-S220. doi: 10.1016/S2152-2650(22)01233-2. PMID: 36163776.

Rios A, Yohannan B, Cervoni-Curet F. AML-154 induction mortality of acute myeloid leukemia patients treated with purine analogues-cytarabine-anthracycline at general hospital. Clin Lymphoma Myeloma Leuk 2022;22(Suppl 2):S219. doi: 10.1016/S2152-2650(22)01232-0

Sridhar A, Yohannan B, Jayan A, Kaur H, Idowu M. A real-world analysis of acquired thrombotic thrombocytopenic purpura: Comparing clinical outcomes of early versus late responders to plasma exchange. Blood 2022;140(Supplement 1):8499–8500. doi: https://doi.org/10.1182/blood-2022-164441

2021 McGovern Medical School Internal Medicine Quality Fair, September 2021
Frances Cervoni-Curet, Arthi Sridhar, Wei Yang, Binoy Yohannan, Julie Rowe, Jessica Jones, Neha Maithel, Adan Rios, Anneliese Gonzalez. Coordinating care in oncologic emergencies: a quality improvement project

Ijele Adimora, Akshitha Yarrabothula, Jordan Thomas, Shelby Irwin, Jeffrey Chen, Arthi Sridhar, Modupe Iwodu. Evaluating physician confidence in identifying and treating acute vaso-occlusive crises in patients with sickle cell disease

CHEST Annual Meeting 2021
Sridhar A, Yang W, Advani S, Jani P, Jafri S. Advanced lung cancer inflammatory index as a prognostic marker for oxygen requirement in patients admitted with SARS-COV-2 infection (Poster session and abstract A524: doi.org/10.1016/j.chest.2021.07.511)

Cervoni-Curet FN, Rios A, Yohannan B, Miao H. Secondary hemophagocytic lymphohistiocytosis (hlh): Five years’ experience at the UTHealth McGovern Medical School at Houston, Texas. J Clin Oncol 2021;39(15_suppl), e19578–e19578. doi: 10.1200/JCO.2021.39.15_suppl.e19578

2020 McGovern Medical School Internal Medicine Quality Fair, September 2020
Yang W, Cervoni-Cuvet F, Rowe J, Gonzalez A, Jones J. Improvement of supportive medicine education in oncological patients to lower cancer therapy related complications and hospitalizations –a quality improvement initiative in cancer care (3rd place winner)


Publications


Hamza Alzghoul, Asad Haider, Faisal Mukhtar, Nausheen Khuddus. Bing-Neel syndrome: a rare neurological complication of Waldenström macroglobulinaemia. BMJ Case Reports 2024;17:e255268. doi:10.1136/bcr-2023-255268

Hamza Alzghoul, Omar Obeidat, Saeed Abughazaleh, Abdallah Al-Ani, Ahmad Al-Jabali, Mohammad Z. Khrais, Mohammed Tarawneh, Hashim Al-Ani, Mohamed F. Ismail, Ariel Ruiz De villa, Asad Haider, Bashar N. Alzghoul, Bilal F. Samhouri. Venous air embolism: a systematic review. Chest Critical Care 2024; 2(1):100049

Cecilia A. Castellano, Tianyi Sun, Deepak Ravindranathan, … Ningjing Li, et al. The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study. Cancer 2024;130(12):2191-2204. PMID 38376917. https://pubmed.ncbi.nlm.nih.gov/38376917/

Pankaj B. Desai, Aniruddha S. Karve, Misam Zawit A, … Ningjing Li, et al. Phase 0/1 pharmacokinetic and pharmacodynamics and safety and tolerability study of letrozole in combination with standard therapy in recurrent high-grade gliomas. Clin Cancer Res 2024:30(10):2068-2077. PMID 38530160. https://pubmed.ncbi.nlm.nih.gov/38530160/

Kok Hoe Chan, Darius Rutazanaa, Curtis Wray, Nirav Thosani, Victor Yang, Putao Cen. Promising response of olaparib in patient with germline ATM-mutated metastatic gastric cancer. J Investig Med High Impact Case Rep 2024;12: 1–7 DOI: 10.1177/23247096241240176 PMID 38504422

Chan KH, Li N, Lador R, Amsbaugh M, Gonzalez A, Cen P. Belzutifan, HIF-2α inhibitor, and clear cell renal cell carcinoma with somatic Von-Hippel-Lindau loss-of-function mutation. J Investig Med High Impact Case Rep 2024 Jan-Dec;12:23247096241231641. doi: 10.1177/23247096241231641. PMID: 38344974 Free PMC article.

Chan KH, Shu T, Al Shaarani M, Cen P. Complete pathologic response with pembrolizumab and enfortumab vedotin in urothelial carcinoma of the upper urinary tract. J Investig Med High Impact Case Rep 2024 Jan-Dec;12:23247096241257333. doi: 10.1177/23247096241257333. PMID: 38804541

Abid MB, Rubin M, Szabo A, Dhakal B, Shah NN, Hamadani M, et al. Infectious complications in patients with hematologic malignancies receiving CD19 Vs. BCMA targeted CAR-T therapy. Transplant Cell Ther 2024;30(2 suppl):S210-S211. doi: https://doi.org/10.1016/j.jtct.2023.12.273

Yadav A, Munir F, Chan KH, et al. Oxygen saturation thresholds in managing sickle cell disease at US children’s hospitals. Pediatr Blood Cancer. Pediatr Blood Cancer 2024;71(4):e30879. doi: 10.1002/pbc.30879

Khan H, Jafry R. A case of hematological malignancy in pregnancy: therapeutic complexities. Hematopoiesos 2024 12 Feb

Tan JY, San BJ, Yeo Y-H, Chan KH, Shaaban HS, Ezekwudo DE, Idowu M. Social vulnerability and sickle cell disease mortality in the US. JAMA Netw Open 2024;7(9): e2440599. doi: 10.1001/jamanetworkopen.2024.40599

Yohannan B, Martinez Gutierrez JC, Chen PR, Rios A. Middle meningeal artery embolization in acute leukemia patients presenting with subdural hematoma. J Hematol 2024;13(1-2):39-45. doi: 10.14740/jh1215. PMID: 38644984; PMCID: PMC11027772.

George B, Chan KH, Rios A. Therapeutic options for chronic myeloid leukemia following the failure of second-generation tyrosine kinase inhibitor therapy. Front Oncol 2024;14 – 2024 | https://doi.org/10.3389/fonc.2024.1446517

George B, Chan KH, Rios A. Early T-cell Precursor (ETP) acute lymphoblastic leukemia (ALL): diagnostic pitfalls, genomic alteration, novel therapeutics, and minimal residual disease monitoring. Front Hematol 2024;3. doi: 10.3389/frhem.2024.1463410

Kok Hoe Chan, Ruhi Buddharaju, Modupe Idowu. EXPRESS: real-world experience of patients with sickle cell disease treated with crizanlizumab. J Investig Med 2023:10815589231220592. doi: 10.1177/10815589231220592.

Li N, Sohal D. Current state of the art: immunotherapy in esophageal cancer and gastroesophageal junction cancer. Cancer Immunol Immunother 2023 Dec;72(12):3939-3952. doi: 10.1007/s00262-023-03566-5. PMID: 37995002; PMCID: PMC10991203.

Abid MB, Rubin M, Szabo A, Longo W, Fenske TS, McCoy C, Lorge A, Abedin S, D’Souza A, Dhakal B, Shah NN, Hamadani M. Efficacy of multiple SARS-CoV-2 vaccine doses in patients with B cell hematologic malignancies receiving chimeric antigen receptor t cell therapy: a contemporary cohort analysis. Transplant Cell Ther 2024;30(3):285-297. doi: 10.1016/j.jtct.2023.12.011. Epub 2023 Dec 23. PMID: 38142942.

Wu JF, Abid H, Szabo A, Abid MB. Impact of age on efficacy and safety of chimeric antigen receptor-T in B-cell acute lymphoblastic leukaemia-A systematic review and meta-analysis. Br J Haematol 2023;203(5):e117-e120. doi: 10.1111/bjh.19149. PMID: 37814795.

Murthy HS, Zhang MJ, Chen K, Ahmed S, Deotare U, Ganguly S, Kansagra A, Michelis FV, Nishihori T, Patnaik M, Abid MB, et al. Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis. Blood Adv 2023;7(22):7007-7016. doi: 10.1182/bloodadvances.2023011308. PMID: 37792849; PMCID: PMC10690553.

Chan KH, Ramdial JL, Hosing C, Srour SA, Alousi AM, Kebriaei P, et al. Outcome of patients with classical Hodgkin lymphoma (cHL) relapsing after an autologous stem-cell transplant (ASCT). Transplant Cell Ther 2023;29(2):S382.

Sridhar A, Singh PK, Parikh K. Immune checkpoint inhibitors in metastatic NSCLC: challenges and future directions. Int J Cancer Care Deliv Published online March 14, 2023. doi:10.53876/001c.72631

Chan KH, Stark JM, Mosquera RA, Brown DL, Menon N, Nguyen TT, Yadav A. Screening for asthma in preschool children with sickle cell disease. J Asthma 2023:1-6 https://doi.org/10.1080/02770903.2023.2187305

Ramdial J, Chan KH, Petitto GS, Andersson B, Valdez B, Nieto Y. Intravenous Busulfan, Dimethylacetamide and neurotoxicity after high-dose pretransplant conditioning chemotherapy. Bone Marrow Transplant 2023 Mar 25. doi: 10.1038/s41409-023-01964-y. Online ahead of print.

Yohannan B, Chan KH, Sridhar A, et al. Warm autoimmune haemolytic anaemia seen in association with primary sclerosing cholangitis in the setting of Klebsiella pneumoniae bacteraemia. BMJ Case Rep CP 2022;15:e248339. doi: 10.1136/bcr-2021-248339

Yohannan B, Sridhar A, Nguyen N, Rios A. Durable remission in a patient with CNS relapse of mantle cell lymphoma treated with Bruton’s tyrosine kinase inhibitors. BMJ Case Rep 2022;15:e249631. http://dx.doi.org/10.1136/bcr-2022-249631

Sridhar A, Yohannan B, Kachira J, Bhama S. Severe pulmonary toxicity related to carfilzomib use: a rare but serious side effect. BMJ Case Rep 2022;15(7):e251173. doi: 10.1136/bcr-2022-251173

Yohannan B, Sridhar A, Kachira JJ, Al Jumaili Z. Synchronous diagnosis of squamous cell carcinoma of the lung and mixed cellularity hodgkin lymphoma of the nasopharynx. Cureus 2022;14(12):e32885. doi:10.7759/cureus.32885

George BS, Yohannan B, Gonzalez A, Rios A. Mixed-phenotype acute leukemia: Clinical diagnosis and therapeutic strategies. Biomedicines 2022;10(8):1974. https://doi.org/10.3390/biomedicines10081974

Yohannan B, Rios A, Buja M. Durable remission in Hodgkin lymphoma treated with one cycle of bleomycin, vinblastine, dacarbazine and two doses of nivolumab and brentuximab vedotin. J Hematol 2022;11(4):154-158.

Yohannan B, George B. B-lymphoid blast phase–chronic myeloid leukemia: Current therapeutics. Int J Molec Sci 2022;23(19):11836. https://doi.org/10.3390/ijms231911836

Yohannan B, Omo-Ogboi AC, Tammisetti VS, Rios A. Synchronous presentation of autoimmune hepatitis and multiple myeloma. J Hematol 2022;11(6):216-222. doi: 10.14740/jh1049

Yohanan B, George B. Current management of chronic myeloid leukemia myeloid blast phase. Clin Med Insights Oncol 2022;16:11795549221139357. doi:10.1177/11795549221139357

Yohannan B, Sridhar A, Kachira JJ, Jafri SH. Glutamic acid decarboxylase (GAD) antibody-positive paraneoplastic stiff person syndrome associated with mediastinal liposarcoma. BMJ Case Rep 2022:15(7): e250639

Idowu M, Haque A, Williams EM, Sridhar A. Patient perception of voxelotor treatment benefit in sickle cell disease. J Investig Med 2022;70(5):1316-1319

Yohannan B, Sridhar A, Nguyen N, Rios A. Durable remission with Bruton’s tyrosine kinase inhibitor therapy in a patient with leptomeningeal disease secondary to relapsed mantle cell lymphoma. BMJ Case Rep 2022;15:e249631

Lee S, Yang W, Arshad H, Lee M, Cen P, Jafri S, Mohlere V, Gonzalez A, Rowe J. Should LI-RADS or liver biopsy be used to diagnose suspected hepatocellular carcinoma? Assessment of current practice patterns and perspective from a metropolitan cancer center. Int J Gastroenterol Liver Disord 2022;2(1);1-4.